Antiplatelet therapy in Coronary Artery Disease

Authors

  • Bakhromkhon Aniskhonovich Alyavi
  • , Kamilovich Uzokov
  • OminaYusupqizi Mukhitdinova

DOI:

https://doi.org/10.37506/ijfmt.v15i3.15628

Keywords:

antiplatelet; coronary artery disease; thrombosis; aspirin; clopidogrel

Abstract

Coronary artery disease (CAD) is the leading cause of morbidity and mortality worldwide. Platelets play
crucial role for the development of thrombus in the atherosclerotic narrowed arteries. This review article
summarizes modern antiplatelet therapies particularly, aspirin and clopidogrel in coronary artery disease,
platelet aggregation, possible risk factors, their mechanism of action and pharmacological properties. In
addition, it provides up to date information regarding acetyl salicylic acid - aspirin and representative of the
thienopyridine – clopidogrel and their role in patients with CAD.

Author Biographies

Bakhromkhon Aniskhonovich Alyavi

Head of the Cardiology Department, Tashkent Paediatric Medical Institute, Tashkent, Uzbekistan

, Kamilovich Uzokov

Researcher of
the Cardiology Department, Republican Specialized Scientific Practical Medical Center of Therapy and Medical
Rehabilitation, Tashkent, Uzbekistan

OminaYusupqizi Mukhitdinova

Master’s Student of the Cardiology Department, Tashkent Paediatric
Medical Institute, Tashkent, Uzbekistan

Published

2021-05-17

How to Cite

Bakhromkhon Aniskhonovich Alyavi, , Kamilovich Uzokov, & OminaYusupqizi Mukhitdinova. (2021). Antiplatelet therapy in Coronary Artery Disease. Indian Journal of Forensic Medicine & Toxicology, 15(3), 2111-2115. https://doi.org/10.37506/ijfmt.v15i3.15628